Evivo Scientific Publications

Evivo is the first and only clinically-proven baby probiotic of its kind. Evivo contains the good bacteria B. infantis, which fully utilizes breast milk to protect baby's gut from potentially harmful bacteria linked to higher risk of colic, eczema, allergies, diabetes, and obesity.

Colonization of breastfed infants by Bifidobacterium longum subsp. infantis EVC001 reduces virulence gene abundance
Colonization of breastfed infants by Bifidobacterium longum subsp.
Activated B. Infantis EVC001 Reduces Colonic Mucin Degradation in Babies
New Study Reveals Activated Bifidobacteria Infantis EVC001 Reduces Colonic Mucin Degradation in Babies

Study results showing that breastfed babies colonized by Bifidobacterium longum subsp. infantis EVC001 displayed significantly less evidence

pH of Baby’s Stool Indicates Loss of Critical Good Bacteria

Alarming Increase In pH of Babies' Stool Indicates Loss of Critical Good Bacteria

A healthy gut microbiome is connected to everything from digestion to cognition to immunity and begins the day you are born.

Evivo Clinical Study Results

Evivo Clinical Study Summary

12/6/2017 — The bacteria in Evivo, Bifidobacterium longum subsp. infantis (B. infantis) is the critically important bacteria in baby’s gut microbiome early in life.

Evivo-Safety-and-Tolerability

Safety & Tolerability Summary

5/30/2017 — One key beneficial bacteria is designed by nature to live in babies’ gut, and thrive in the presence of human breast milk: Bifidobacterium (including B. infantis).